An observational study in Hip Fractures and In-hospital Mortality, sponsored by Assiut University. Not yet recruiting. Open to participants aged 65 Months and older. Per ClinicalTrials.gov, last updated 2026-10-14.
Sponsored by Assiut University · Observational
To assess the incidence of in-hospital mortality among geriatric patients with hip fractures and to identify its potential predictors
Population ageing is a major global demographic transition. In 2020, approximately 1 billion people worldwide were aged 60 years or older. This number is projected to increase to 1.4 billion by 2030, when approximately one in six people globally will be aged ≥60 years. In Egypt, approximately 9.77 million people are aged ≥60 years, representing nearly 10% of the total population.
Hip fractures are a major health problem among older adults, causing substantial morbidity, functional decline, loss of independence, prolonged hospitalization, and increased mortality .
Falls are the predominant mechanism of hip fracture in older adults, with more than 90% of fractures attributable to falls, . This emphasizes the importance of underlying skeletal fragility in addition to fall characteristic .
Osteoporosis is a major contributor to skeletal fragility and susceptibility to hip fracture after low-energy trauma . BMI also influences both fracture risk and prognosis; low BMI is associated with greater fracture susceptibility, while underweight patients have higher mortality after hip fracture .
Comorbidities may further increase fracture susceptibility and affect outcomes. Diabetes, hypertension, cardiovascular disease, and chronic kidney disease have been associated with increased fracture risk among older adults .
Hip fractures are associated with considerable in-hospital mortality, while outcomes vary according to patient characteristics, comorbidity burden, and clinical management. However, prospective studies identifying independent predictors of in-hospital mortality, particularly in Egyptian geriatric populations, remain limited .
Therefore, this study aims to determine the incidence of in-hospital mortality and identify its predictors among geriatric patients with hip fractures
848 studies on the registry are indexed under Hip Fractures; 160 are open to participants now.
This study's planned enrollment of 141 is close to the median of 142 across 277 observational studies indexed under Hip Fractures.
Browse Hip Fractures studies →Assiut University is the lead sponsor of 5,050 studies on the registry; 2,174 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients aged ≥65 years diagnosed with a hip fracture and admitted to the Trauma Unit during the study period.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Incidence of In-Hospital Mortality
The study participants will be followed from hospital arrival and initial diagnosis of hip fracture, through their subsequent surgical management, and throughout the postoperative period until hospital discharge or in-hospital death, whichever occurs first
Time frame: About 1 month from hospital arrival till in-hospital death or discharge
No study locations are listed for this record.
Plan to share: Undecided
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.